Finance

Lists
Q2 2027 earnings • released • EPS beat +18.98% • Revenue beat +2.69%
See results
ROSSARI:NSE
Rossari Biotech Ltd
₹435.00
-4.32%
(-19.65) 1D
Oct 19, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for ROSSARI...
Open
₹452.50
High
₹458.00
Low
₹431.35
Mkt. cap
24.27B
Avg. vol.
74.39K
Volume
143.77K
Dividend
0.11%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 10, 2026
P/E ratio
16.00
52-wk high
₹674.75
52-wk low
₹375.00
EPS
₹27.20
No. of employees
585
Open
₹452.50
High
₹458.00
Low
₹431.35
Mkt. cap
24.27B
Avg. vol.
74.39K
Volume
143.77K
Dividend
0.11%
Quarterly dividend
₹0.13
Ex-dividend date
Jul 10, 2026
P/E ratio
16.00
52-wk high
₹674.75
52-wk low
₹375.00
EPS
₹27.20
No. of employees
585
News stories
From web sources and news partners
Profile
Rossari Biotech is an Indian chemical manufacturing company with a focus on specialty chemicals. It is also engaged in production of specialty enzymes and chemicals in India that is used in the pharmaceuticals, paper, construction, textiles, nutrition and animal health industries. The company was started in 2003 as a partnership firm titled Rossari Labtech and was incorporated into a company in 2009 and was renamed as Rossari Biotech. It has two R&D facilities, one at Silvassa manufacturing facility and the second in Dahej. Wikipedia
About Rossari Biotech Ltd
CEO-
Employees585
FoundedAug 10, 2009
Headquarters-
SectorSpeciality chemicals
Websiterossari.com
Last report
Oct 19, 2026
Fiscal period
Q2 2027
₹7.02 / ₹5.90
+18.98%beat
Revenue / Est. (INR)
6.98B / 6.79B
+2.69%beat
Fiscal Q2 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
5.82B
6.85B
6.97B
6.98B
Cost of goods sold
4.01B
5.04B
4.91B
-
Cost of revenue
4.01B
5.04B
4.91B
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
402.56M
463.26M
440.44M
-
Operating expense
1.32B
1.44B
1.51B
-
Total operating expenses
5.32B
6.48B
6.42B
-
Operating income
492.59M
369.04M
550.05M
-
Other non operating income
5.09M
-27.71M
31.87M
-
EBT including unusual items
425.01M
642.43M
476.72M
-
EBT excluding unusual items
425.01M
437.87M
476.72M
-
Income tax expense
97.27M
182.76M
125.77M
-
Effective tax rate
22.89%
28.45%
26.38%
-
Other operating expenses
717.50M
736.59M
817.11M
-
Net income
327.74M
459.67M
350.95M
-
Net profit margin
5.63%
6.71%
5.03%
-
Earnings per share
5.91
8.29
6.33
7.02
Interest and investment income
-
13.51M
-
-
Interest expense
-76.65M
-90.59M
-109.77M
-
Net interest expenses
-76.65M
-77.08M
-109.77M
-
Depreciation and amortization charges
196.14M
235.28M
256.15M
-
EBITDA
645.98M
544.80M
725.80M
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps